Complications of radiologic contrast in patients with myasthenia gravis

Mehyar Mehrizi, Robert Pascuzzi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Use of older contrast agents during radiologic imaging in patients with myasthenia gravis (MG) has been associated with increased myasthenic symptoms and adverse drug reactions (ADRs). The effects of newer contrast agents have not been determined. A retrospective review of imaging safety in MG was conducted. Three hundred fifty-four imaging studies were analyzed. Procedures included 189 computed tomography (CT) images with and 106 without intravenous (IV) contrast and 42 magnetic resonance images (MRIs) with and 17 without contrast. In 108 patients for whom there was formal documentation of presence or absence of an immediate adverse response, only 1 who received CT IV contrast had an ADR (rate 0.93%). No ADRs or weakness were reported in patients who received MRI IV contrast. Our data suggest there is no significant immediate increased risk of myasthenic weakness with the use of modern radiologic contrast agents. The rate of ADRs in MG patients who receive CT IV contrast is now very low (0.93%).

Original languageEnglish
Pages (from-to)443-444
Number of pages2
JournalMuscle and Nerve
Volume50
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Myasthenia Gravis
Drug-Related Side Effects and Adverse Reactions
Contrast Media
Muscle Weakness
Tomography
Magnetic Resonance Spectroscopy
Documentation
Safety

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)
  • Physiology

Cite this

Complications of radiologic contrast in patients with myasthenia gravis. / Mehrizi, Mehyar; Pascuzzi, Robert.

In: Muscle and Nerve, Vol. 50, No. 3, 2014, p. 443-444.

Research output: Contribution to journalArticle

@article{c8ada600558c4492896c7df6ffa992f9,
title = "Complications of radiologic contrast in patients with myasthenia gravis",
abstract = "Use of older contrast agents during radiologic imaging in patients with myasthenia gravis (MG) has been associated with increased myasthenic symptoms and adverse drug reactions (ADRs). The effects of newer contrast agents have not been determined. A retrospective review of imaging safety in MG was conducted. Three hundred fifty-four imaging studies were analyzed. Procedures included 189 computed tomography (CT) images with and 106 without intravenous (IV) contrast and 42 magnetic resonance images (MRIs) with and 17 without contrast. In 108 patients for whom there was formal documentation of presence or absence of an immediate adverse response, only 1 who received CT IV contrast had an ADR (rate 0.93{\%}). No ADRs or weakness were reported in patients who received MRI IV contrast. Our data suggest there is no significant immediate increased risk of myasthenic weakness with the use of modern radiologic contrast agents. The rate of ADRs in MG patients who receive CT IV contrast is now very low (0.93{\%}).",
author = "Mehyar Mehrizi and Robert Pascuzzi",
year = "2014",
doi = "10.1002/mus.24254",
language = "English",
volume = "50",
pages = "443--444",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Complications of radiologic contrast in patients with myasthenia gravis

AU - Mehrizi, Mehyar

AU - Pascuzzi, Robert

PY - 2014

Y1 - 2014

N2 - Use of older contrast agents during radiologic imaging in patients with myasthenia gravis (MG) has been associated with increased myasthenic symptoms and adverse drug reactions (ADRs). The effects of newer contrast agents have not been determined. A retrospective review of imaging safety in MG was conducted. Three hundred fifty-four imaging studies were analyzed. Procedures included 189 computed tomography (CT) images with and 106 without intravenous (IV) contrast and 42 magnetic resonance images (MRIs) with and 17 without contrast. In 108 patients for whom there was formal documentation of presence or absence of an immediate adverse response, only 1 who received CT IV contrast had an ADR (rate 0.93%). No ADRs or weakness were reported in patients who received MRI IV contrast. Our data suggest there is no significant immediate increased risk of myasthenic weakness with the use of modern radiologic contrast agents. The rate of ADRs in MG patients who receive CT IV contrast is now very low (0.93%).

AB - Use of older contrast agents during radiologic imaging in patients with myasthenia gravis (MG) has been associated with increased myasthenic symptoms and adverse drug reactions (ADRs). The effects of newer contrast agents have not been determined. A retrospective review of imaging safety in MG was conducted. Three hundred fifty-four imaging studies were analyzed. Procedures included 189 computed tomography (CT) images with and 106 without intravenous (IV) contrast and 42 magnetic resonance images (MRIs) with and 17 without contrast. In 108 patients for whom there was formal documentation of presence or absence of an immediate adverse response, only 1 who received CT IV contrast had an ADR (rate 0.93%). No ADRs or weakness were reported in patients who received MRI IV contrast. Our data suggest there is no significant immediate increased risk of myasthenic weakness with the use of modern radiologic contrast agents. The rate of ADRs in MG patients who receive CT IV contrast is now very low (0.93%).

UR - http://www.scopus.com/inward/record.url?scp=84907424311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907424311&partnerID=8YFLogxK

U2 - 10.1002/mus.24254

DO - 10.1002/mus.24254

M3 - Article

VL - 50

SP - 443

EP - 444

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 3

ER -